Medical Care of the Liver Transplant Patient

Contributors, ix
 
Preface, xv
 
Part 1 Management of the potential transplant recipient
 
1 Selection and evaluation of the recipient (including retransplantation), 3
Audrey Coilly and Didier Samuel
 
2 Monitoring the patient awaiting liver transplantation, 13
Andreas Geier and Beat Müllhaupt
 
3 Management of portal hypertension, 26
Juan Carlos Garcia-Pagan, Juan G. Abraldes and Jaime Bosch
 
4 Management of renal disease in the liver transplant candidate, 39
Andrés Cárdenas and Pere Ginès
 
5 Management of hepatopulmonary syndrome and portopulmonary hypertension, 51
Victor I. Machicao and Michael B. Fallon
 
6 Psychiatric and substance abuse evaluation of the potential liver transplant recipient, 62
Thomas P. Beresford
 
7 Organ allocation in liver transplantation: ethics, organ supply, and evidencebased practice, 75
Nicole Siparsky, David Axelrod and Richard B. Freeman
 
8 Viral hepatitis and transplantation, 88
Geoffrey W. McCaughan
 
9 Metabolic liver diseases, 97
Maureen M.J. Guichelaar and Michael R. Charlton
 
10 Cholestatic and autoimmune liver disease, 110
Ulrich Beuers
 
11 Hepatocellular carcinoma, 121
Maria Reig, Alejandro Forner and Jordi Bruix
 
12 Cholangiocarcinoma, 133
Howard C. Masuoka, Gregory J. Gores and Charles B. Rosen
 
13 Rare indications for liver transplantation, 145
Stevan A. Gonzalez
 
14 Liver transplantation in HIV patients, 155
Marion G. Peters and Peter G. Stock
 
15 Living-donor liver transplantation, 162
Robert S. Brown Jr
 
16 Fulminant hepatic failure, 176
Michael A. Heneghan and William Bernal
 
Part 2 Donor issues and management in the perioperative period
 
17 Extended-criteria donor, 191
Ashraf Mohammad El-Badry and Mickael Lesurtel
 
18 Liver transplantation using donors after cardiac death, 201
Paolo Muiesan, Laura Tariciotti and Chiara Rocha
 
19

Pierre-Alain Clavien, MD, PhD, FACS, FRCS (Eng), FRCS (Ed), Professor and Chairman, Department of Surgery. Head, Division of Visceral & Transplantation Surgery, University Hospital Zurich, Switzerland
Professor Clavien is a world-wide renowned surgeon-scientist, currently professor and chairman of the Department of Surgery in Zurich, Switzerland. His areas of research include organ preservation, liver ischemia-reperfusion injury and regeneration, and pathogenesis of cancer, as well as outcome research. He received many competitive grants and awards, including one of the most prestigious prices for scientific research, the Otto Naegeli Award.
 
Dr James Trotter is the Medical Director of Liver Transplantation at Baylor University Medical Center at Dallas. Dr. Trotter's primary interests include end-stage liver disease and the management of liver transplant candidates and recipients. Dr. Trotter specializes in hepatitis C, ascites, complications of portal hypertension, including esophageal varices and hepatic encephalopathy. He also has vast experience in the management of medical complications after liver transplantation including immunosuppression in liver transplant recipients and the treatment of hepatitis C before and after liver transplantation.

"This new edition does a good job addressing more current issues in liver transplantation. It succinctly provides an excellent base of understanding, guiding readers through a variety of indications for liver transplantation to help them understand the operative and chronic management of these patients." ( Doody's , 20 July 2012)

"I can recommend the book with enthusiasm. It will find a place on my bookshelf." ( Gastroenterology , 1 December 2012)

"This new edition does a good job addressing more current issues in liver transplantation. It succinctly provides an excellent base of understanding, guiding readers through a variety of indications for liver transplantation to help them understand the operative and chronic management of these patients." ( Doody's , 20 July 2012)